Re: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma
J Urol
.
2018 Jan;199(1):23-25.
doi: 10.1016/j.juro.2017.09.134.
Epub 2017 Oct 10.
Author
M Pilar Laguna
PMID:
29310178
DOI:
10.1016/j.juro.2017.09.134
No abstract available
Publication types
Comment
MeSH terms
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms
Pyrroles
Sunitinib*
Substances
Pyrroles
Sunitinib